Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.33 -0.11 (-0.54%)
As of: Oct 21, 2026 · 11:41 AM EDT

Acadia Pharmaceuticals (ACAD) Operating Expenses (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Operating Expenses of $270.12 million in Q2 2026, up 16.3% from $232.19 million a year earlier but down 0.9% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Operating Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, Acadia Pharmaceuticals' Operating Expenses came in at $1.05 billion as of Jun 30, 2026, up 34.5% year-over-year; for FY2025, it was $966.69 million, up 33.0% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $727 million in FY2024 (-9.1%), $799.82 million in FY2023 (+8.0%), $740.83 million in FY2022 (+13.2%) and $654.58 million in FY2021 (-10.1%).
  • Quarterly Operating Expenses has ranged from $106.1 million in Q4 2024 to $272.68 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for six consecutive quarters, with growth averaging 20.4% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 151.3% in Q4 2025, against a decline of 45.9% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $272.68 million (Q1 2026), $266.6 million (Q4 2025) and $242.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 10.12 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 10.56 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 9.70 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 18.20 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 6.68 Bn
10 Acadia Pharmaceuticals 3.49 Bn 19.20 Mn 279.64 Mn 270.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 270.12 Mn
Mar 31, 2026 272.68 Mn
Dec 31, 2025 266.60 Mn
Sep 30, 2025 242.88 Mn
Jun 30, 2025 232.19 Mn
Mar 31, 2025 225.03 Mn
Dec 31, 2024 106.10 Mn
Sep 30, 2024 218.76 Mn
Jun 30, 2024 211.53 Mn
Mar 31, 2024 190.62 Mn
Dec 31, 2023 196.10 Mn
Sep 30, 2023 269.48 Mn
Jun 30, 2023 162.20 Mn
Mar 31, 2023 172.05 Mn
Dec 31, 2022 182.55 Mn
Sep 30, 2022 161.58 Mn
Jun 30, 2022 168.21 Mn
Mar 31, 2022 228.48 Mn
Dec 31, 2021 175.42 Mn
Sep 30, 2021 146.91 Mn
API Access

Acadia Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY